Danny L. Dearen is President & CFO of Axonics, Inc.. Currently has a direct ownership of 23,777 shares of AXNX, which is worth approximately $1.6 Million. The most recent transaction as insider was on Sep 29, 2023, when has been sold 7,675 shares (Common Stock) at a price of $56.87 per share, resulting in proceeds of $436,477. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.8K
0% 3M change
158.39% 12M change
Total Value Held $1.6 Million

Danny L. Dearen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 29 2023
SELL
Open market or private sale
$436,477 $56.87 p/Share
7,675 Reduced 24.4%
23,777 Common Stock
Sep 29 2023
BUY
Exercise of conversion of derivative security
-
11,250 Added 26.35%
31,452 Common Stock
May 26 2023
SELL
Open market or private sale
$398,270 $49.79 p/Share
7,999 Reduced 46.5%
9,202 Common Stock
Apr 21 2023
SELL
Open market or private sale
$1,204,400 $60.22 p/Share
20,000 Reduced 53.76%
17,201 Common Stock
Apr 21 2023
BUY
Exercise of conversion of derivative security
$187,421 $14.19 p/Share
13,208 Added 26.2%
37,201 Common Stock
Apr 20 2023
SELL
Open market or private sale
$120,080 $60.01 p/Share
2,001 Reduced 7.7%
23,993 Common Stock
Apr 20 2023
BUY
Exercise of conversion of derivative security
$28,394 $14.19 p/Share
2,001 Added 7.15%
25,994 Common Stock
Mar 31 2023
SELL
Open market or private sale
$828,900 $55.26 p/Share
15,000 Reduced 38.47%
23,993 Common Stock
Mar 31 2023
BUY
Exercise of conversion of derivative security
$208,200 $13.88 p/Share
15,000 Added 27.78%
38,993 Common Stock
Feb 01 2023
SELL
Open market or private sale
$197,129 $60.73 p/Share
3,246 Reduced 11.92%
23,993 Common Stock
Jan 31 2023
SELL
Open market or private sale
$642,642 $61.14 p/Share
10,511 Reduced 27.84%
27,239 Common Stock
Jan 31 2023
BUY
Exercise of conversion of derivative security
-
25,250 Added 40.08%
37,750 Common Stock
Jan 31 2023
BUY
Grant, award, or other acquisition
-
5,000 Added 28.57%
12,500 Common Stock
Sep 13 2022
SELL
Open market or private sale
$49,594 $75.6 p/Share
656 Reduced 8.04%
7,500 Common Stock
Aug 11 2022
SELL
Open market or private sale
$3,563,000 $71.26 p/Share
50,000 Reduced 85.98%
8,156 Common Stock
Aug 11 2022
BUY
Exercise of conversion of derivative security
$332,268 $8.86 p/Share
37,502 Added 39.2%
58,156 Common Stock
Mar 01 2022
SELL
Open market or private sale
$1,140,445 $57.28 p/Share
19,910 Reduced 49.08%
20,654 Common Stock
Mar 01 2022
BUY
Exercise of conversion of derivative security
$318,335 $25.82 p/Share
12,329 Added 23.31%
40,564 Common Stock
Feb 25 2022
SELL
Open market or private sale
$570,000 $57.0 p/Share
10,000 Reduced 26.15%
28,235 Common Stock
Feb 25 2022
BUY
Exercise of conversion of derivative security
$200,100 $20.01 p/Share
10,000 Added 20.73%
38,235 Common Stock
Feb 03 2022
SELL
Open market or private sale
$908,416 $48.62 p/Share
18,684 Reduced 39.82%
28,235 Common Stock
Feb 03 2022
BUY
Exercise of conversion of derivative security
-
36,919 Added 44.04%
46,919 Common Stock
Feb 01 2022
SELL
Open market or private sale
$969,400 $48.47 p/Share
20,000 Reduced 66.67%
10,000 Common Stock
Feb 01 2022
BUY
Exercise of conversion of derivative security
$283,800 $14.19 p/Share
20,000 Added 40.0%
30,000 Common Stock
Jan 31 2022
BUY
Grant, award, or other acquisition
-
11,000 Added 34.38%
21,000 Common Stock
DLD

Danny L. Dearen

President & CFO
Irvine, CA

Track Institutional and Insider Activities on AXNX

Follow Axonics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AXNX shares.

Notify only if

Insider Trading

Get notified when an Axonics, Inc. insider buys or sells AXNX shares.

Notify only if

News

Receive news related to Axonics, Inc.

Track Activities on AXNX